Abstract
We have accomplished an asymmetric synthesis of each enantiomer of 4,4-difluoroglutamic acid. This α-amino acid has been of interest in medicinal chemistry circles. Key features of the synthesis include highly scalable procedures, a Reformatsky-based coupling reaction, and straightforward functional group manipulations to make the parent amino acid. Enantioenrichment derives from an enzymatic resolution of the synthetic material. Conversion of the optically enriched compounds to orthogonally protected forms allows selective formation of peptide bonds. 4,4- Difluoroglutamic acid, in a suitably protected form, is also shown to exhibit enhanced catalytic activity in both an oxidation reaction and a reduction reaction, in comparison to the analogous glutamic acid derivative.
Keywords: difluoroglutamic acid, enzymatic kinetic resolution, Brønsted-acid catalyst
Introduction
One of the foci of the research in our laboratory is the use of amino acids and peptides as catalysts for synthetic organic transformations.i Central to the function of these peptides are specific catalytically active amino acids that, in and of themselves, may mediate the chemical transformation of interest. In some respects, this strategy may be analogous to the roles of catalytic residues in enzymes.ic,ii Recently we have been studying the potential catalytic activity of peptides containing carboxylic acid side-chains, in the forms of aspartic or glutamic acids, and have found their applications in the epoxidation of olefins,iii and the Baeyer-Villiger oxidation of ketones.iv In these processes, we have gained evidence that the carboxylic acid side chain may engage in transient conversion to a peracid intermediate (Figure 1a).v Notably, aspartic and glutamic acid moieties could also be relevant for the development of chiral Brønsted acid based catalysts, a subfield of asymmetric catalysis that has seen explosive interest in recent years.vi Of course, the role of these amino acid side chains in enzymatic proton transfer catalysis, and as H-bond donors or acceptors, is also ubiquitous.vii The most successful non-enzymatic Brønsted acid catalysts reported to date appear to exhibit pKa values that are lower than typical aspartic or glutamic acid residues.viii Therefore, we wondered if 4,4-difluoroglutamic acid, by virtue of the inductive effect of the fluorine atoms,ix could provide a boost in catalytic activity for Brønsted acid catalyzed processes, over its proteinogenic glutamic counterpart. Such a residue then might be inserted into peptide libraries, facilitating the search for new chiral Brønsted acid catalysts (Figure 1b).
Figure 1.
(a) Acid-peracid catalytic cycle. (b) Brønsted acid catalyzed reactions
The compound of interest 4,4-difluoroglutamic acid has been synthesized before, in both racemic and optically pure forms.x Excellent as these pioneering precedents are, we felt that we needed more rapid access to large quantities of the material, and unambiguously in each enantiomeric form. Additionally the parent compound 4,4-difluoroglutamic acid per se cannot be incorporated into a peptide directly, without being protected orthogonally. This unglamorous, though necessary aspect was not well-described in the chemical literature.
Results and Discussion
We were very much attracted to the simplicity and robustness of the racemic synthesis developed by Tsukamoto and Coward,xb and therefore based our work on this efficient route (Scheme 1). Our synthesis began from chlorodifluoroacetic acid 1, an inexpensive commercially available acid. Its diethylamide derivative 2 was subjected to a Reformatzky reaction to give an N,O-acetal 3. For this step, we found that the original procedure,xi which heats acid-washed zinc powder with reactants at 65 °C, was not suitable for large scale synthesis. The zinc insertion into 2 is highly exothermic, yet it does not take place unless being heated to approximately 50 °C; consequently, the reaction is prone to thermal runaway. We examined experimentally various physical and chemical methods of zinc activation,xii including ultrasound, Zn/Cu couple, Zn/Ag couple, TMSCl and 1,2-dibromoethane as additives. None were particularly effective. Eventually we found that adding a catalytic amount of CeCl3 allowed the reaction to proceed smoothly at room temperature,xiii and gave an acceptable yield of 3 in 53%. This modification should make for a safer procedure and one that is more easily scalable to the desired 20 g level. The N,O-acetal 3 was subsequently hydrolyzed to give the corresponding hemiacetal 4, by employing a strong cationic exchange resin Amberlyst 15 as the catalyst.xiv The hemiacetal 4 was then transformed according to the multi-step procedure developed by Tsukamoto and Coward to give 4,4-difluoroglutamic acid 9. We have made two minor modifications to their procedure to suit our needs. The reaction temperature for the acetylation of intermediate 5 was raised by 30 °C from room temperature, which shortened the reaction time from overnight as reported, to half an hour. We also chose to convert the crude hydrochloride salt 9 to the Cbz-protected amino acid 10 directly, thus bypassing a laborious ion-exchange chromatography step.
Scheme 1.
Synthesis of DL-13a. a Reagents and conditions: (i) SOCl2, DMF, 50–90 °C; Et2NH, Et2O, 0–23 °C; (ii) Zn, CeCl3, Et2SO4, DMF, 0–65 °C; (iii) Amberlyst 15 H, EtOH/H2O, rt; (iv) CH2NO2(COOEt), Et2NH, THF, 0–23 °C; (v) Ac2O, cat. H2SO4, DCM, 55 C °C; (vi) NaBH4, THF, 0 °C; (vii) Raney Ni, 1 atm H2, EtOH, rt; (viii) 12M HCl, 100 °C; (ix) CbzCl, NaHCO3, H2O, 0–23 °C; (x) TMSCHN2, PhMe/MeOH, rt; (xi) LiOH, MeOH/H2O, 0 °C; (xii) tBuBr, K2CO3, BnNEt3Cl, AcNMe2, 55 °C.
From intermediate 10, the key to the eventual orthogonal protection of 4,4-difluoroglutamic acid was the differential functionalization of the two carboxylic acids. While we were unable to find conditions that could selectively esterify the carboxylic acids in 10, we found that the dimethyl ester derivative 11 could be readily hydrolyzed to give 12 with total regioselectivity, due to the activating effect of the geminal difluoro group.xv From 12, a tert-butyl ester was installed to give an orthogonally protected difluoroglutamic acid 13.xvi
We next endeavored to resolve the racemic amino acid ester 13 into the individual enantiomers by enzymatic hydrolysis (Scheme 2). A survey of the literature revealed that subtilisin, an inexpensive commercially available enzyme, was often employed for this purpose.xvii There were two issues however, that needed to be addressed. First, the substrate 13 is not appreciably soluble in water, the preferred solvent for enzymatic reaction; second, while the serine protease subtilisin Carlsberg is optimal under alkaline conditions, substrate 13 is sensitive to base. After experimenting unsuccessfully with organic-aqueous biphasic conditions, we eventually decided to develop conditions with a homogeneous reaction medium, which was buffered at neutral pH, and with a water-miscible cosolvent added to improve the solubility of the substrate. From a screen of cosolvents (Table 1), we find that the enzyme was the most active with DMSO as the cosolvent.
Scheme 2.
Enzymatic kinetic resolution of DL-13a. aReagents and conditions: (i) subtilisin Carlsberg, DMSO/phosphate buffer, pH 7.0, rt; (ii) Me3SnOH, 1,2-DCE, 70 °C.
Table 1.
Screening of cosolvent for enzymatic resolution.a
![]() | |
|---|---|
| Cosolvent | Yieldb % |
| tBuOH | 7 |
| THF | 1 |
| 1,4-dioxane | 1 |
| Acetone | 4 |
| MeCN | 3 |
| DMF | 10 |
| DMSO | 39 |
| [bmim] [BF4] | 12 |
Conditions: 26 mM substrate in 40:60 pH 7.0 sodium phosphate buffer/cosolvent mixture, 0.77 eq buffer salts, 73U enzyme/mmol substrate, 37 °C, 20 h.
Uncalibrated yield measured by integrating UV 215 nm absorption in HPLC trace.
Using DMSO as the preferred cosolvent, we next attempted to optimize other reaction variables (Table 2). The amount of the sodium phosphates buffer salts, which was critical to the reaction, was found to be optimal at 1.5 equivalent (entries 1–3), yielding the highest selectivity factor. The enzymatic reaction was also very sensitive to the water content of the reaction medium. Using the aforementioned phosphate buffer, we found that a 60:40 ratio of DMSO to aqueous buffer was optimal (entry 1). Higher water content caused lower selectivity, presumably caused by higher background hydrolysis rate (entry 4); while higher DMSO content led to enzyme denaturation (entry 5). Furthermore, we found that the enzyme was functioning more selectively at lower temperatures, albeit at a lower reaction rate (entries 6 – 7), which could be compensated by increasing the catalyst loading (entry 8). Finally we were pleased to discover that the outcome of the reaction improved when conducted on a larger scale (entry 9). Under the optimized resolution conditions, the amino acid ester 13 was obtained in ≥99% ee; and the amino acid 14 was obtained in >90% ee. The recovery of the two compounds was close to the theoretical limit of 50%. The reaction has since been run on multi-gram scale without difficulty (Scheme 2).
Table 2.
Optimizing the reaction conditions for enzymatic resolution.a
| Entry | Enzyme loadingb (U/mmol) | Phosphatec (eq) | DMSO (volume %) | Temp. (°C) | Yieldd % | ee % | krele |
|---|---|---|---|---|---|---|---|
| 1 | 77 | 1.5 | 60 | 37 | 53 | 82 | 16 |
| 2 | 77 | 3.0 | 60 | 37 | 70 | 94 | 7 |
| 3 | 77 | 6.0 | 60 | 37 | 67 | 98 | 12 |
| 4 | 77 | 1.5 | 50 | 37 | 67 | 90 | 7 |
| 5 | 77 | 1.5 | 70 | 37 | 7 | 4 | 3 |
| 6 | 77 | 1.5 | 60 | 30 | 46 | 76 | 40 |
| 7 | 77 | 1.5 | 60 | 23 | 39 | 60 | 58 |
| 8 | 269 | 1.5 | 60 | 23 | 52 | 92 | 40 |
| 9f | 269 | 1.5 | 60 | 23 | 53 | >99 | >80 |
| 10 | 0 | 1.5 | 60 | 23 | 4 | NDg | - |
Reactions were run using 13 mM substrate in DMSO/pH 7.0 sodium phosphate buffer mixture under the specified conditions for 12–17 h. Reactions were conducted on 5–10 mg scale.
The amount of enzyme used, in enzyme unit, per mmol of substrate.
The equivalents of phosphates relative to substrate.
Uncalibrated yield measured by integrating UV 215 nm absorption in HPLC trace.
Nominal selectivity factor calculated using formula by Kaganxviii.
Reaction was run at 100 mg scale.
Not determined.
Having obtained the protected amino acid L-14, its enantiomer D-14 could be made by removing the methyl ester in D-13. In a quite surprising event, unforeseen by us, the presence of the geminal difluoro group in D-13 made the tert-butyl ester more susceptible to hydrolysis than the methyl ester. We have screened a number of reagents and conditions for the deprotection of the methyl ester, including LiOH, K2CO3, TMSOK and LiI. None were high-yielding and selective for this substrate. Finally we discovered that trimethyltin hydroxide could remove the methyl ester in high yield and without racmization,xix thus giving the other enantiomer of the protected amino acid. While the entire synthetic sequence is perhaps lengthy, it only makes uses of four chromatographic purification steps. Most of the intermediates are carried forward without purification.
With a robust and scalable synthesis of the monomeric amino acid in hand, the stage is set for the investigation of its reactivity, and potential catalytic utilities. While these studies are underway in our laboratory, we wish to present here two reactions that illustrate the benefit from the increased acidity of the difluoroglutamic acid: the Baeyer-Villiger oxidation of cyclobutanones,xx and the transfer hydrogenation of imines.xxi Both processes are known to be catalyzed by Brønsted acids. In the experiments presented below, we found that the difluoroglutamic catalyst gave substantial rate acceleration over its corresponding identical glutamic counterpart, thus confirming our initial hypothesis. For example, as shown in Scheme 3, we observe the 3-phenyl-oxetanone 16a undergoes oxidative ring expansion in the presence of glutamic acid derivative 15a (10 mol%) to give lactone 16b in only 28% yield within 18 h. On the other hand, the difluorinated catalyst analog 15b delivers the product in 79% yield within the same time frame. By the same token, glyoximine derivative 17 is reduced upon exposure to the Hantszsch ester and catalyst 15a (10 mol%) to afford phenylglycine derivative 18 in 20% yield (Scheme 4). Once again, catalyst 15b exhibits greater activity, with 18 produced in 68% yield under the analogous conditions. The products of these reactions, 16b and 18, are not surprisingly racemic, given the simplicity of the catalyst. However once this amino acid is incorporated into peptide structures, there are ample opportunities for creating highly enantioselective catalysts, as we have demonstrated numerous times before in related systems.ia–c,iii These preliminary observations confirm our original hypothesis, and provide the basis of our ongoing studies with the title compound.
Scheme 3.
Difluoroglutamic acid catalyzed Baeyer-Villiger oxidation.
Scheme 4.
Difluoroglutamic acid catalyzed transfer hydrogenation.
Conclusions
We have developed a robust and scalable synthesis of a key amino acid for studies in asymmetric Brønsted acid catalysis. Of additional significance, 4,4-difluoroglutamic acid derivatives have proven of interest in medicinal chemistry settings,xxii and the synthesis we report here may prove useful to chemists beyond the context of our specific goals. In this context, we have synthesized both enantiomers of orthogonally protected 4,4-difluoroglutamic acids in a protected form suitable for use in peptide coupling. The synthesis yields products with high optical purity, and requires few purification steps. Preliminary experiments have demonstrated that the difluoroglutamic acid is a promising strong Brønsted acid catalyst. We are currently engaged in the study of peptides incorporating this amino acid.
Experimental Section
General information
Anhydrous CeCl3 was prepared by slowly flame drying the commercially available heptahydrate under vacuum, and then cooled to rt under vacuum. Purchased zinc powder was purified by first washing with 2M HCl, then rinsing with water, acetone and diethyl ether, and finally flame dried under vacuum. All other reagents and solvents were used as received without purification, unless otherwise noted.
The enzyme subtilisin Carlsberg (EC 3.4.21.62) from Bacillus licheniformis was purchased and was used as received. Enzyme activity was assayed by the manufacturer. One unit enzyme is defined by the manufacturer as the amount of enzyme that can hydrolyze casein to produce 1.0 µmol of tyrosine per minute at pH 7.5 and 37 °C, as detected colorimetrically by Folin-Ciocalteu reagent.
Unless otherwise noted, all reactions were carried out at bench top conditions without exclusion of air or moistures.
Proton and carbon NMR chemical shifts were recorded relative to TMS, and were calibrated to either internally added TMS, or residual solvent signal. Fluorine NMR chemical shifts were recorded relative to FCCl3, and were calibrated automatically by the spectrometer using solvent deuterium lock signal. Fluorine NMR spectra were recorded without proton decoupling. All NMR data were acquired at ambient temperature.
Infra-red spectra were acquired on a Fourier transform spectrometer equipped with a diamond crystal for attenuated total reflectance measurement. Only peaks in the carbonyl region are reported.
The procedures leading up to the preparation of 13 and 14 are described for representive experiments repeated several times on convenient scale. We have since used this procedure to successfully make more than 20 g of 13 per batch, and have resolved DL-13 on 5 g scale.
2-Chloro-N,N-diethyl-2,2-difluoroacetamide (2)
See SI for a diagram of the apparatus used for this reaction. Thionyl chloride (65 mL, 0.89 mol) was slowly added from an addition funnel to a solution of chlorodifluoroacetic acid (50 mL, 0.58 mol) in dry DMF (400 mL). The solution was then heated in an oil bath to 50 °C with stirring. Chlorodifluoroacetic chloride was produced as a gas (b.p. 26 °C), which was condensed via a dry-ice cooled condenser to another flask containing a solution of diethylamine (210 mL, 2.02 mol) in dry diethyl ether (500 mL) at 0 °C. The temperature of the oil bath was gradually increased from 50° C to 90 °C to maintain a steady rate of chlorodifluoroacetic chloride production. After 2 h, the oil bath was removed. The reactions were left stirring overnight. Afterwards, the ethereal solution was filtered. The filtrate was washed with water (3 × 500 mL), 1M HCl (3 × 500 mL), dried over magnesium sulfate and then evaporated in vacuo to dryness to give the product as a pale yellow green liquid (68.7 g, 64%). Proton and fluorine NMR spectra were recorded in CDCl3, and were consistent with literature data.xi
3-(Dimethylamino)-3-ethoxy-N,N-diethyl-2,2-difluoropropanamide (3)
[N.B. this is a highly exothermic reaction, and therefore it is very important to monitor the reaction temperature closely, and apply cooling swiftly if the temperature rises rapidly above 70 °C, in order to avoid thermal runaway.] A solution of diethyl sulfate (50 mL, 374 mmol) in dry DMF (90 mL) was heated under nitrogen at 90°C for 2 h, then cooled with an ice bath to < 10 °C. To the solution α-chloroamide 2 (34.7 g, 187 mmol), zinc powder (25.0 g, 375 mmol) and finally anhydrous cerium trichloride (1.86 g, 7.55 mmol) were added. After stirring under nitrogen at < 10 °C for 25 min, the reaction was taken out of the ice bath. As the reaction mixture warmed up to rt, the reaction gradually became highly exothermic. An ice bath was used to cool the reaction mixture when necessary, such that the temperature never exceeded 60 °C. After the exotherm subsided, the reaction mixture was further stirred under nitrogen at rt for 2 h. After adding more anhydrous cerium trichloride (516 mg, 2.09 mmol) to the reaction mixture, it was heated in a 65 °C oil bath for 1 h, then filtered to give a viscous dark brown opaque solution. The solution was continuously extracted with pentane (250 mL) overnight.
The extract was evaporated in vacuo to remove pentane. To the residual liquid was added saturated aqueous sodium bicarbonate solution (100 mL) and diethyl ether (100 mL). The resulting heterogeneous mixture was filtered. The organic layer was separated out. The aqueous layer was extracted with diethyl ether (2 × 100 mL). The combined ethereal extract was washed with water (2 × 50 mL), brine (50 mL), dried over sodium sulfate, and concentrated to give a dark red viscous oil as the crude product. The crude product was distillated under vacuum (1.9 Torr). Product 3 was collected at 80 °C as a clear colourless liquid (24.8 g, 53%). Proton and fluorine NMR spectra were recorded in CDCl3, and were consistent with literature data.xi
4-Ethoxycarbonyl-N,N-diethyl-2,2-difluoro-4-nitrobutanamide (7)
To a solution of N,O-acetal 3 (41.5 g, 164 mmol) in ethanol (370 mL) was added Amberlyst 15 resin (33.0 g, 4.99 mequiv H+/g) and water (6.0 mL, 333 mmol). After stirring at rt overnight, the mixture was filtered. The resulting brown solution was concentrated in vacuo to dryness, and then re-dissolved in diethyl ether (300 mL). Copious amount of anhydrous potassium carbonate was added to the solution, which was then vigorously stirred for 3 h. The mixture was filtered through Celite, then concentrated in vacuo to give the crude hemiacetal 4 as a clear yellow oil (36.7 g).
The oil 4 was dissolved in dry THF (200 mL). To the solution in an ice-bath, ethyl nitroacetate (18.5 mL, 167 mmol) and diethylamine (24.0 mL, 230 mmol) were added. The solution was stirred at rt under nitrogen overnight. Afterwards the volatile components in the reaction solution were evaporated in vacuo. In an ice-bath, to the residual oil was added 0.6 M HCl solution (400 mL). The mixture was extracted with EtOAc (3 × 200 mL). The organic extract was washed with 0.5 M HCl solution (3 × 100 mL), brine (100 mL), dried over MgSO4 and concentrated in vacuo to give crude alcohol 5 as a viscous red oil (50.9 g). [N.B. thorough removal of diethylamine from the crude product mixture by vacuum drying is critical for the subsequent acetylation reaction.]
The oil 5 was dissolved in dry DCM (150 mL). To it acetic anhydride (20.5 mL, 211 mmol) and 18 M sulfuric acid (0.45 mL, 8.1 mmol) were added. The resulting solution was heated to refluxed (55 °C). After 30 min, the reaction solution was poured into water (300 mL), extracted with EtOAc (3 × 200 mL) and then DCM (200 mL). The combined organic phase was washed with brine (3 × 100 mL), dried over MgSO4 and concentrated in vacuo to give acetylated alcohol 6 as a viscous red oil.
The oil 6 was dissolved in dry THF (750 mL). To the solution at 0 °C, sodium borohydride (6.32 g, 165 mmol) was added. The resulting solution was stirred under nitrogen at 0 °C. After 2 h, the reaction solution was concentrated in vacuo to dryness. The residual material was re-dissolved in EtOAc (200 mL). To the solution was added carefully 1 M HCl (300 mL). After vigorous stirring, the organic phase was separated out. The aqueous phase was extracted with EtOAc (2 × 200 mL). The combined organic phase was washed with brine (100 mL), dried over MgSO4 and concentrated in vacuo to give crude product 7 as a viscous yellow oil, which was purified by flash column (ID 13 cm × L 26 cm) chromatography on silica gel, eluting with 16:100 to 20:100 EtOAc/hexanes. The purified product was a clear colorless oil (23.9 g, 49% from 3). Proton and fluorine NMR spectra were recorded in CDCl3, and were consistent with literature data.xb
N-Benzyloxycarbonyl-4,4-difluoro-DL-glutamic acid (10)
A slurry of Raney nickel in water (35 mL wet volume) was centrifuged. The supernatant water was removed. The metallic residue was re-suspended in absolute ethanol (35 mL). The centrifugation-suspension cycle was repeated two more times, to obtain a suspension of Raney nickel in ethanol. The suspension was added to a solution of nitro compound 7 (23.9 g, 80.7 mmol) in absolute ethanol (200 mL). The mixture was stirred at rt overnight under a balloon of hydrogen. The reaction mixture was then filtered through Celite to give a cloudy green solution, which was evaporated in vacuo to dryness to give crude amide 8 as a viscous green oil.
The oil 8 was dissolved in 12 M HCl (300 mL) then stirred at 100 °C overnight. Hydrochloric acid was removed by vacuum distillation, at temperature not exceeding 100 °C. A yellow oil was obtained after the distillation. A small amount of water was added to dissolve the oil. The solution was then evaporated in vacuo to dryness. This step was repeated several times to remove as much HCl as possible. In the end, a viscous yellow green oil was obtained as the crude difluoroglutamic acid 9.
The crude 9 was dissolved in water (550 mL) at 0 °C. To it was added sodium bicarbonate (54.5 g, 647 mmol) portionwise. To the alkaline suspension, benzyl chloroformate (24 mL, 163 mmol) was then added. The suspension was stirred at rt overnight. Afterwards the reaction suspension was then washed with chloroform (100 mL × 5). The aqueous phase was acidified in an ice bath with 12 M HCl (70 mL), then extracted with EtOAc (150 mL × 4). The aqueous phase was saturated with brine (250 mL), then extracted again with EtOAc (150 mL). The combined organic extract was washed with brine (100 mL), dried over magnesium sulfate and evaporated in vacuo to dryness to give a clear yellow oil. The oil gradually solidified under vacuum to give dicarboxylic acid 10 as a pale red-orange solid (13.74 g, 54% from 7). Proton and fluorine NMR spectra were recorded in CD3OD. The product was approximately 90% pure, by visual inspection of its NMR spectra. The compound's proton and fluorine NMR spectra, as well as its mass spectrum, were consistent with literature data.xv
Dimethyl N-benzyloxycarbonyl-4,4-difluoro-DL-glutamate (11)
To a solution of di-carboxylic acid 10 (5.95 g, 18.8 mmol) in 5:2 toluene/methanol (175 mL) was added dropwise an excess amount (approx. 25 mL) of a 2 M solution of trimethylsilyldiazomethane in hexanes, until gas evolution ceased, and the reaction solution stayed golden yellow in color. Acetic acid was then added dropwise to the reaction solution, until gas evolution ceased and the golden yellow color disappeared. The reaction solution was concentrated to give a viscous oil, which was then diluted with ethyl acetate (300 mL), washed with saturated aqueous solution of sodium bicarbonate (100 mL), brine (100 mL), dried over magnesium sulfate, and evaporated to give a viscous oil. The oil was purified by flash chromatography on silica gel (8-66% ethyl acetate in hexanes) to give diester 11 as a clear colorless oil, which gradually solidified into a white waxy solid (4.89 g, 76%). Rf 0.62 (2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.40–7.28 (m, 5H), 5.44 (d, J = 8.3 Hz, 1H), 5.13, 5.10 (ABq, J = 12.2 Hz, 2H), 4.61 (td, J = 7.8, 4.8 Hz, 1H), 3.774 (s, 3H), 3.766 (s, 3H), 2.79 (qd, J = 15.5, 4.7 Hz, 1H), 2.64 (qd, J = 15.4, 7.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 170.9, 164.2 (t, 2JCF = 32.3 Hz), 155.6, 136.0, 128.5, 128.2, 128.1, 114.8 (t, 1JCF = 251.5 Hz), 67.1, 53.4, 52.8, 48.9 (t, 3JCF = 4.9 Hz), 36.1 (t, 2JCF = 23.5 Hz); 19F NMR (376 MHz, CDCl3) δ −104.12 (t, 3JHF = 15.6 Hz); IR (FT-ATR) 1769, 1732, 1685 cm-1; MS (ESI) calculated for [C15H17F2NO6 + H]+ 346.1102, found 346.1105.
5-tert-Butyl 1-methyl N-benzyloxycarbonyl-4,4-difluoro-DL-glutamate (DL-13)
To a solution of diester 11 (4.89 g, 14.2 mmol) in methanol (180 mL) at 0 °C was added a solution of lithium hydroxide monohydrate (0.606 g, 14.2 mmol) in water (60 mL) portionwise. After stirring for 2 min, 2 M hydrochloric acid (25 mL) and brine (350 mL) were added to the reaction solution, which was then extracted with EtOAc (3 × 150 mL). The organic phase was washed with water (2 × 100 mL), brine (100 mL), dried over magnesium sulfate and evaporated to dryness to give crude monoester 12 as a pale yellow oil, which was then dissolved in N,N-dimethylacetamide (110 mL). Benzyltriethylammonium chloride (3.26 g, 14.2 mmol), potassium carbonate (49 g, 351 mmol) and tert-butylbromide (79 mL, 687 mmol) were added to the solution. The mixture was stirred at 55 °C for 18 h. Afterwards the reaction mixture was partitioned between water (500 mL) and ethyl acetate (500 mL). The organic phase was washed with water (3 × 250 mL), brine (100 mL), dried over magnesium sulfate and evaporated to dryness to give a yellow oil, which was purified by flash chromatography on silica gel (6-50% ethyl acetate in hexanes), to afford tert-butyl ester DL-13 as a white solid (3.92 g, 71% from 11). Rf 0.39 (3:1 hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.38–7.27 (m, 5H), 5.51 (d, J = 8.1 Hz, 1H), 5.10 (s, 2H), 4.61 (td, J = 7.9, 4.7 Hz, 1H), 3.75 (s, 3H), 2.70 (qd, J = 15.6, 4.7 Hz, 1H), 2.59 (qd, J = 15.4, 7.6 Hz, 1H), 1.49 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 171.1, 162.4 (t, 2JCF = 31.4 Hz), 155.7, 136.1, 128.6, 128.3, 128.2, 114.8 (t, 1JCF = 252.3 Hz), 85.2, 67.3, 53.0, 49.3 (t, 3JCF = 4.4 Hz), 36.1 (t, 2JCF = 23.6 Hz), 27.7; 19F NMR (376 MHz, CDCl3) δ −103.9, −104.3 (ABX2, 2JFF = 266 Hz, 3JHF = 15.7 Hz); IR (FT-ATR) 1750, 1713, 1693 cm-1; MS (ESI) calculated for [C18H23F2NO6 + H]+ 388.1572, found 388.1582.
Kinetic resolution of DL-13
To a solution of DL-13 (1.00 g, 2.58 mmol) in DMSO (120 mL), sodium phosphate buffer (pH 7.0, 400 mM, 10 mL), water (50 mL), and a solution of subtilisin (59.9 mg) in water (20 mL) were added sequentially. An ice-bath was used to keep the reaction mixture at rt during the addition process. The solution was stirred at rt for 13 h, then acidified with 10% citric acid solution in water (300 mL), and saturated with brine (300 mL). The solution was extracted with ethyl acetate (4 × 200 mL). The organic extract was washed with water (5 × 300 mL), brine (300 mL), dried over sodium sulfate and evaporated to dryness to yield a clear colorless oil. The oil was purified by flash column chromatography. The column was first eluted with 75:25:1 hexanes/EtOAc/AcOH to collect 5-tert-butyl 1-methyl N-benzyloxycarbonyl-4,4-difluoro-D-glutamate (D-13), then with 50:50:1 hexanes/EtOAc/AcOH to collect N-benzyloxycarbonyl-5-tert-butyl-4,4-difluoro-L-glutamic acid (L-14).
5-tert-Butyl 1-methyl N-benzyloxycarbonyl-4,4-difluoro-D-glutamate (D-13)
5-tert-Butyl 1-methyl N-benzyloxycarbonyl-4,4-difluoro-D-glutamate (D-13) was obtained as a clear colorless oil (447 mg, 45%), which gradually solidifies into a translucent white solid upon standing. Its mass spectrum, proton, carbon and fluorine NMR spectra were identical to those of the racemic compound DL-13. Rf (75:25:1 hexanes/EtOAc/AcOH) 0.34; IR (FT-ATR) 1749, 1725, 1714 cm-1; (c = 1.0, chloroform); Chiral HPLC (Chiralpak OJ-H, 250 × 4.6 mm, 85:15 hexanes/EtOH, 1.0 mL/min, 25 °C, UV 215 nm) tL = 10.4 min, tD = 13.4 min, >99% ee.
N-Benzyloxycarbonyl-5-tert-butyl-4,4-difluoro-L-glutamic acid (L-14)
N-Benzyloxycarbonyl-5-tert-butyl-4,4-difluoro-L-glutamic acid (L-14) was obtained as a clear colorless oil. The oil was submerged in hexane, then scratched with a glass rod rapidly. The oil quickly solidifies into a white solid (451 mg, 47%). Rf (50:50:1 hexanes/EtOAc/AcOH) 0.34; 1H NMR (500 MHz, CDCl3) δ 10.03 (s, br), 7.38–7.26 (m, 5H), 5.56 (d, J = 8.3 Hz, 1H), 5.11, 5.10 (ABq, J = 12.3 Hz, 2H), 4.62 (td, J = 8.0, 4.4 Hz, 1H), 2.74 (qd, J = 15.6, 4.3 Hz, 1H), 2.62 (qd, J = 15.3, 7.7 Hz, 1H), 1.48 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 175.0, 162.4 (t, 2Jcf = 31.4 Hz), 156.1, 135.8, 128.5, 128.3, 128.2, 114.6 (t, 1Jcf = 252.3 Hz), 85.4, 67.5, 49.1 (t, 3Jcf = 3.9 Hz), 35.6 (t, 2Jcf = 23.6 Hz), 27.6; 19F NMR (376 MHz, CDCl3) δ −103.7, −104.0 (ABX2, 2Jff = 266 Hz, 3Jhf = 15.7 Hz); IR (FT-ATR) 3294, 1758, 1746, 1727, 1716, 1693 cm-1; MS (ESI) calculated for [C17H21F2NO6 + H]+ 374.1415, found 374.1419; (c = 1.0, chloroform); Chiral HPLC (Chiralcel OD, 250 × 4.6 mm, 950:50:1 hexanes/iPrOH/TFA, 1.0 mL/min, 25 °C, UV 215 nm) tL = 20.8 min, tD = 25.6 min, 92% ee.
N-Benzyloxycarbonyl-5-tert-butyl-4,4-difluoro-D-glutamic acid (D-14)
To a solution of D-13 (447 mg, 1.15 mmol) in dry 1,2-dichloroethane (40 mL) under nitrogen at 70 °C, trimethyltin hydroxide (642 mg, 3.48 mmol) was added. After stirring for 3 h, the reaction solution was diluted with EtOAc (120 mL) and washed successively with 10% citric acid solution in water (3 × 50 mL) and brine (50 mL), dried over magnesium sulfate, then evaporated to dryness to afford a clear colorless oil. The oil was purified by flash chromatography (50:50:1 hexanes/EtOAc/AcOH). After purification, the afforded product was submerged under hexanes, then scratched rapidly with a glass rod, until all of the product solidified. The hexanes solvent was evaporated in vacuo to give the product D-14 as a white powder (312 mg, 72%). Its mass spectrum, infrared spectrum, proton, carbon and fluorine NMR spectra were identical to those of its enantiomer L-14. (c = 1.0, chloroform); Chiral HPLC (Chiralcel OD, 250 × 4.6 mm, 950:50:1 hexanes/iPrOH/TFA, 1.0 mL/min, 25 °C, UV 215 nm) tL = 21.2 min, tD = 24.7 min, 99% ee.
(S)-4-benzyloxycarbonylamino-5-oxo-5-(1-pyrrolidinyl)-pentanoic acid (15a)
A solution of Cbz-Glu(OtBu)-OH (501 mg, 1.47 mmol), HOBt hydrate (583 mg, 3.73 mmol), EDCHCl (724 mg, 3.70 mmol) and pyrrolidine (freshly distillated, 330 µL, 3.72 mmol) in DCM (5 mL) was heated by microwave at 60 °C for 20 min. Afterwards, the solution was diluted with EtOAc (100 mL), washed with 10% aqueous citric acid solution (3 × 30 mL), saturated aqueous sodium bicarbonate solution (3 × 30 mL), brine (30 mL), dried over sodium sulfate and evaporated in vacuo to dryness to give a clear colorless oil, which was then dissolved in 1:1 DCM/TFA (5 mL) and stirred at rt. After 1 h, all volatile components in the reaction solution was evaporated in vacuo to give a pale yellow oil as the crude product, which was purified by flash column chromatography (85:15:1 EtOAc/hexanes/AcOH) on silica gel to afford the product as a white foam (456 mg, 93%). Rf (85:15:1 EtOAc/hexanes/AcOH) 0.23; 1H NMR (400 MHz, CDCl3) δ 7.37–7.27 (m, 5H), 6.06 (d, J = 8.5 Hz, 1H), 5.09 (s, 2H), 4.59 (td, J = 8.8, 3.9 Hz, 1H), 3.65–3.34 (m, 4H), 2.55–2.38 (m, 2H), 2.11–1.77 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 176.7, 170.4, 156.6, 136.4, 128.6, 128.2, 128.0, 67.0, 51.8, 46.7, 46.3, 29.6, 27.6, 26.0, 24.2; IR (FT-ATR) 3278, 1702, 1605 cm-1; (c = 0.9, chloroform); MS (ESI) calculated for [C17H22N2O5 + H]+ 335.1607, found 335.1605.
(S)-4-benzyloxycarbonylamino-2,2-difluoro-5-oxo-5-(1-pyrrolidinyl)-pentanoic acid (15b)
A solution of L-14 (0.38 g, 1.0 mmol), HOBt hydrate (187 mg, 1.20 mmol), EDC HCl (233 mg, 1.19 mmol) and pyrrolidine (212 µL, 2.39 mmol) in DCM (5 mL) was stirred overnight at rt. Afterwards, the solution was diluted with EtOAc (100 mL), washed with 10% aqueous citric acid solution (2 × 30 mL), saturated aqueous sodium bicarbonate solution (30 mL), brine (30 mL), dried over sodium sulfate and evaporated in vacuo to dryness to give a clear colorless oil. The oil was purified by flash column chromatography (8:2 hexanes/acetone) to give a clear colorless oil (398 mg, 92%), a portion of which (299 mg) was then dissolved in 30:1:1 TFA/Et3SiH/H2O (9.6 mL) and stirred at rt. After 4 h, all volatile components in the reaction solution was evaporated in vacuo. The residual oil was purified by reverse phase chromatography on C18 column (2–50% MeCN in H2O, with 0.1% TFA in both eluents). The product fractions were evaporated in vacuo to give a white solid. In order to remove the remaining trace amount of TFA, the product was dissolved in water and evaporated in vacuo for three times, followed by addition and evaporation of toluene for three times. It was then dissolved in water/MeOH, and lyophilized to give a white powder (202 mg, 73% overall). The final product was verified to be free from TFA by fluorine NMR. The compound exhibits multiple conformers in NMR at rt, the dominant major conformer is as follows: 1H NMR (500 MHz, DMSO) δ 14.7 (br, 1H), 7.80 (d, J = 8.5 Hz, 1H), 7.39–7.28 (m, 5H), 5.02 (s, 2H), 4.55 (td, J = 8.0, 5.3 Hz, 1H), 3.52 (dt, J = 9.8, 6.8 Hz, 1H), 3.43 (dt, J = 10.0, 6.8 Hz, 1H), 3.32–3.22 (m, 2H), 2.62–2.46 (m, 1H), 2.43–2.28 (m, 1H), 1.92–1.82 (m, 2H), 1.80–1.70 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 169.6, 164.8 (br), 155.9, 135.9, 128.3, 127.9, 127.7, 115 (v br), 67.0, 47.2, 46.8, 46.5, 36.5 (t, 2Jcf = 23.1 Hz), 25.6, 23.8; 19F NMR (376 MHz, DMSO) δ −103.5, −104.3 (ABX2, 2Jff = 256 Hz, 3Jhf = 16.8 Hz); IR (FT-ATR) 3277, 1708, 1610 cm-1; (c = 1.0, chloroform); MS (ESI) calculated for [C17H20F2N2O5 + H]+ 371.1419, found 371.1422.
Baeyer-Villiger oxidation of cyclobutanone
To a solution of cyclobutanone 16axxiii (28.0 mg, 0.192 mmol) and catalyst 15b (7.1 mg, 0.019 mmol) in CDCl3 (0.50 mL), 30% aqueous hydrogen peroxide (39.1 µL, 0.383 mmol) was added. The mixture was vigorously stirred at rt for 18 h, before bromoform (16.8 µL, 0.192 mmol) was added to the reaction mixture. The reaction mixture was then examined by proton NMR. The product yield (79%) was determined by comparing the integration of the internal standard bromoform (singlet at 6.82 ppm) and the carboxylate methylene protons of the lactone product 16b (dd at 4.67 and 4.27 ppm). The proton NMR spectrum of the product was consistent with literature data.xxiii Chiral HPLC (Chiralpak IA, 250 × 4.6 mm, 99:1 hexanes/EtOH, 1.0 mL/min, 25 °C, UV 215 nm) t = 41.5, 48.4 min, racemic.
Transfer hydrogenation of imine
A mixture of imine 1724 (≥9:1 Z/E mixture of isomers, 53.4 mg, 0.198 mmol), diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate (55 mg, 0.22 mmol) and a solution of catalyst 15b (7.4 mg, 0.020 mmol) in CDCl3 (0.50 mL). The mixture gradually became a solution as it stirred overnight for 17 h at rt. An NMR internal standard 1,3,5-trimethoxybenzene (11.8 mg, 0.0702 mmol) was added to the reaction solution, which was then examined by proton NMR. The product yield (68%) was determined by comparing the integration of the aryl protons of the internal standard (singlet at 6.08 ppm) and the para-methoxyphenyl protons of the product 18 (doublet at 6.53 ppm). The proton NMR spectrum of the product was consistent with literature data.xxiv Chiral HPLC (Chiralpak IB, 250 × 4.6 mm, 90:10 hexanes/iPrOH, 0.5 mL/min, 25 °C, UV 245 nm) t = 14.5, 15.1 min, racemic.
Supplementary Material
Acknowledgments
This work is supported by National Institutes of Health, National Institute of General Medical Sciences (GM096403).
Footnotes
Supporting information available. NMR spectra and HPLC traces are available for compounds 11–15. A diagram of the apparatus to prepare compound 2 is also provided. This material is provided free of charge via the Internet at http://pubs.acs.org.
References
- i.(a) Jarvo ER, Miller SJ. Tetrahedron. 2002;58:2481–2495. [Google Scholar]; (b) Miller SJ. Acc Chem Res. 2004;37:601–610. doi: 10.1021/ar030061c. [DOI] [PubMed] [Google Scholar]; (c) Colby Davie E, Mennen SM, Xu Y, Miller SJ. Chem Rev. 2007;107:5759–5812. doi: 10.1021/cr068377w. [DOI] [PubMed] [Google Scholar]; (d) List B. Tetrahedron. 2002;58:5573–5590. [Google Scholar]; (e) Revell JD, Wennemers H. Curr Opin Chem Biol. 2007;11:269–278. doi: 10.1016/j.cbpa.2007.05.015. [DOI] [PubMed] [Google Scholar]; (f) Wennemers H. Chem Commun. 2011 doi: 10.1039/C1CC15237H. [DOI] [Google Scholar]
- ii.Knowles RR, Jacobsen EN. Proc Natl Acad Sci USA. 2010;107:20678–20685. doi: 10.1073/pnas.1006402107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- iii.(a) Peris G, Jakobsche CE, Miller SJ. J Am Chem Soc. 2007;129:8710–8711. doi: 10.1021/ja073055a. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Jakobsche CE, Peris G, Miller SJ. Angew Chem Int Ed. 2008;47:6707–6711. doi: 10.1002/anie.200802223. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Kolundzic F, Noshi MN, Tjandra M, Movassaghi M, Miller SJ. J Am Chem Soc. 2011;133:9104–9111. doi: 10.1021/ja202706g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- iv.Peris G, Miller SJ. Org Lett. 2008;10:3049–3052. doi: 10.1021/ol8010248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- v.Rebek J, McCready R, Wolf S, Mossman J. Org Chem. 1979;44:1485–1493. [Google Scholar]
- vi.For general reviews on catalysis by chiral Brønsted acid: Terada M. Synthesis. 2010:1921–1982.Terada M. Chem Comm. 2008:4097–4112. doi: 10.1039/b807577h.Akiyama T. Chem Rev. 2007;107:5744–5758. doi: 10.1021/cr068374j.Akiyama T, Itoh J, Fuchibe K. Adv Synth Catal. 2006;348:999–1010.For reviews on specific types of reactions catalyzed by chiral Brønsted acid: Johnston JN, Muchalski H, Troyer TL. Angew Chem Int Ed. 2010;49:2290–2298. doi: 10.1002/anie.200904828.You SL, Cai Q, Zeng M. Chem Soc Rev. 2009;38:2190–2201. doi: 10.1039/b817310a.
- vii.For examples of proton transfer and hydrogen bonding in enzymatic systems: Silverman DN, McKenna R. Acc Chem Res. 2007;40:669–675. doi: 10.1021/ar7000588.Hedstrom L. Chem Rev. 2002;102:4501–4524. doi: 10.1021/cr000033x.Northrop DB. Acc Chem Res. 2001;34:790–797. doi: 10.1021/ar000184m.For reviews of hydrogen-bonding mediated catalysis by small molecules Yu XH, Wang W. Chem Asian J. 2008;3:516–532. doi: 10.1002/asia.200700415.Doyle AG, Jacobsen EN. Chem Rev. 2007;107:5713–5743. doi: 10.1021/cr068373r.Taylor MS, Jacobsen EN. Angew Chem Int Ed. 2006;45:1520–1543. doi: 10.1002/anie.200503132.Connon SJ. Chem Eur J. 2006;12:5418–5427. doi: 10.1002/chem.200501076.Takemoto Y. Org Biomol Chem. 2005;3:4299–4306. doi: 10.1039/b511216h.Schreiner PR. Chem Soc Rev. 2003;32:289–296. doi: 10.1039/b107298f.
- viii.Christ P, Lindsay AG, Vormittag SS, Neudörfl JM, Berkessel A, O'Donoghue AC. Chem Eur J. 2011;17:8524–8528. doi: 10.1002/chem.201101157. [DOI] [PubMed] [Google Scholar]
- ix.Schlosser M. Angew Chem Int Ed. 1998;110:1496–1513. doi: 10.1002/(SICI)1521-3773(19980619)37:11<1496::AID-ANIE1496>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
- x.(a) Kitagawa O, Hashimoto A, Kobayashi Y, Taguchi T. Chem Lett. 1990:1307–1310. [Google Scholar]; (b) Tsukamoto T, Kitazume T, McGuire JJ, Coward JK. J Med Chem. 1996;39:66–72. doi: 10.1021/jm950514m. [DOI] [PubMed] [Google Scholar]; (c) Konas DW, Coward JK. Org Lett. 1999;1:2105–2107. doi: 10.1021/ol991150l. [DOI] [PubMed] [Google Scholar]; (c) Ding Y, Wang JQ, Abboud KA, Xu YL, Dolbier WR, Richards NGJ. J Org Chem. 2001;66:6381–6388. doi: 10.1021/jo015754q. [DOI] [PubMed] [Google Scholar]; (d) Meffre P, Dave RH, Leroy J, Badet B. Tetrahedron Lett. 2001;42:8625–8627. [Google Scholar]; (e) Dave R, Badet B, Meffre P. Amino Acids. 2003;24:245–261. doi: 10.1007/s00726-002-0410-9. [DOI] [PubMed] [Google Scholar]
- xi.Tsukamoto T, Kitazume T. J Chem Soc Perkin Trans 1. 1993:1177–1181. [Google Scholar]
- xii.(a) Erdik E. Tetrahedron. 1987;43:2203–2212. [Google Scholar]; (b) Ocampo R, Dolbier WR., Jr Tetrahedron. 2004;60:9325–9374. [Google Scholar]
- xiii.(a) Shen Y, Qi M. J Fluorine Chem. 1994;67:229–232. [Google Scholar]; (b) Ocampo R, Dolbier WR, Jr, Abboud KA, Zuluaga F. J Org Chem. 2002;67:72–78. doi: 10.1021/jo015778x. [DOI] [PubMed] [Google Scholar]
- xiv.Bijeire L, Denier C, Mulliez M, De Lima WT. Phosphorus Sulfur. 2007;182:881–891. [Google Scholar]
- xv.Tsukamoto T, Coward JK. J Org Chem. 1996;61:2497–2500. [Google Scholar]
- xvi.Chevallet P, Garrouste P, Malawska B, Martinez J. Tetrahedron Lett. 1993;34:7409–7412. [Google Scholar]
- xvii.(a) Miyazawa T. Amino Acids. 1999;16:191–213. doi: 10.1007/BF01388169. [DOI] [PubMed] [Google Scholar]; (b) Bordusa F. Chem Rev. 2002;102:4817–4867. doi: 10.1021/cr010164d. [DOI] [PubMed] [Google Scholar]
- xviii.Kagan HB, Fiaud JC. Topic in Stereochemistry. 1998;18:249. [Google Scholar]
- xix.Nicolaou KC, Estrada AA, Zak M, Lee SH, Safina BS. Angew Chem Int Ed. 2005;44:1378–1382. doi: 10.1002/anie.200462207. [DOI] [PubMed] [Google Scholar]
- xx.Xu S, Wang Z, Zhang X, Zhang X, Ding K. Angew Chem Int Ed. 2008;47:2840–2843. doi: 10.1002/anie.200705932. [DOI] [PubMed] [Google Scholar]
- xxi.Li GL, Liang YX, Antilla JC. J Am Chem Soc. 2007;129:5830–5831. doi: 10.1021/ja070519w. [DOI] [PubMed] [Google Scholar]
- xxii.Winter HC, Ueda T. Neurochem Res. 2008;33:223–231. doi: 10.1007/s11064-007-9493-8. [DOI] [PubMed] [Google Scholar]
- xxiii.Malkov AV, Friscourt F, Bell M, Swarbrick ME, Koèovský PJ. J Org Chem. 2008;73:3996–4003. doi: 10.1021/jo800246g. [DOI] [PubMed] [Google Scholar]
- xxvi.Shang G, Yang Q, Zhang X. Angew Chem Int Edit. 2006;45:6360–6362. doi: 10.1002/anie.200601540. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






